Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Healsea® Babykids in the Treatment of Acute Infectious Rhinitis Symptoms in Children

NCT05819203 is registered in ClinicalTrials.gov with Lallemand Pharma AG as lead sponsor.

NCT NCT05819203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Healsea® Babykids in the Treatment of Acute Infectious Rhinitis Symptoms in Children
Lead sponsor
Lallemand Pharma AG
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2023
Completion date
May 16, 2023
Enrollment
200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, rhinitis viral